There has been scrutiny of the AstraZeneca COVID-19 vaccine on the issue of the very rare clots, with a higher incidence in younger people.
There has been scrutiny of the AstraZeneca COVID-19 vaccine on the issue of the very rare clots, with a higher incidence in younger people.
Comments
Post a Comment